Tag: Board

Pro Cap NYC, LLC Open Letter to the Board of Directors of United States Antimony Corporation

 Pro Cap NYC, LLC is pleased to release its letter presented to the Board of Directors of United States Antimony Corporation (the “Company”) on July 11, 2022. As detailed in its letter, Pro Cap believes that the Company, with more than $20 million in net cash, the only refining and processing facility for antimony in the United States and demand outlook that has not been as favorable in decades is positioned to become a meaningful part of the supply chain for domestically sourced antimony, which is critical for national defense and the green energy transition. To realize this potential, Bert ... Read more

Pirelli Board Approves New Sustainability-Linked Bank Line of 400 Million Euro

Financial Structure Optimized, Debt Maturities Covered until First Half of 2024 Milan – WEBWIRE – Friday, June 24, 2022 The Board of Directors of Pirelli met and approved the underwriting with a select pool of international banks of a sustainability-linked credit line for an amount up to 400 million euro, with a 19-month maturity that enables the further optimization of the group’s financial structure. The new line, to be used to reimburse part of the debt maturing in 2023, contributes to preserving the liquidity margin, with debt maturities covered until the first half of 2024. The ... Read more

Canada – Patented Medicine Prices Review Board Imposes Deadline for Motions for Leave to Intervene in the Redetermination of Board Decisions Regarding the Excessive Pricing of Soliris Dated September 27 and November 8, 2017

The Patented Medicine Prices Review Board will hold a public rehearing in the matter of the price of the patented medicine Soliris, and Alexion Pharmaceuticals Inc., the pharmaceutical company that holds the patent for Soliris and sells the medicine in Canada. April 1, 2022 – Ottawa, ON – Patented Medicine Prices Review Board The Patented Medicine Prices Review Board will hold a public rehearing in the matter of the price of the patented medicine Soliris, and Alexion Pharmaceuticals Inc., the pharmaceutical company that holds the patent for Soliris and sells the medicine in Canada. Further details on the public rehearing ... Read more

NCR Board Nominates Two New Board Members

ATLANTA – WEBWIRE – Wednesday, March 23, 2022  NCR Corporation (NYSE: NCR), a leading enterprise technology provider, announced Laura Sen, former non-executive chair and CEO of BJ’s Wholesale Club Inc., and Glenn Welling, principal and chief investment officer at Engaged Capital, have been nominated for election to our Board of Directors. Ms. Sen is the retired non-executive chair and CEO of BJ’s Wholesale Club Inc., a Fortune 500 retail chain. In that role, she was responsible for all day-to-day operations and more than 25,000 employees. Under her leadership, the company grew the number of retail stores to 216 ... Read more

The Central Board recommends 8.10% rate of interest to its subscribers for the year 2021-22

The 230th meeting of Central Board of Trustees, EPF was held today during the AKAM Iconic Week in Guwahati under the Chairmanship of Shri Bhupendra Yadav, Union Minister for Labour & Employment and Environment, Forest & Climate Change, Vice-Chairmanship of Shri RameshwarTeli, Union Minister of State for Labour & Employment, Petroleum & Natural Gas and Co-Chairmanship of Shri Sunil Barthwal, Secretary Labour & Employment and the Member Secretary Smt. NeelamShammi Rao, Central P F Commissioner. The Central Board recommended 8.10% annual rate of interest to be credited on EPF accumulations in members’ accounts for the ... Read more